James S. Bus PhD, DABT, ATS

Dr. Bus has over 40 years of toxicology experience focused on research and evidence-based literature analyses informing potential health risks associated with chemical and pesticide exposures. He offers chemical-specific and strategic toxicology expertise addressing development, stewardship, and regulatory needs to individual industry clients and business consortia, and government and non-governmental agencies. Dr. Bus provides expertise in the design, implementation, and interpretation of toxicity tests and mode of action and dose-response/exposure evaluations furthering the translation of toxicology findings to risk assessment. His expertise includes target-organ and endpoint-specific modes of action, and specific toxicity of chemicals including chlorinated organics, ethylene glycol, and glycol ethers, aromatic derivatives benzene, styrene, aniline, and others, and pesticides such as 2,4-D and glyphosate.